olanzapine/samidorphan decreases outcomes of fentanyl transdermal by pharmacodynamic antagonism. Contraindicated. Samidorphan elicits opioid antagonistic outcomes and raises hazard of precipitating acute opioid withdrawal in patients depending on opioids.fentanyl transdermal will enhance the degree or outcome of isavuconazonium sulfate by influenci